Trial Profile
A retrospective trial evaluated efficacy of pemetrexed in patients with platinum-resistant advanced urothelial carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 13 May 2016 New trial record